Literature DB >> 7033301

Comparative antibody titers to Actinobacillus actinomycetemcomitans in juvenile periodontitis, chronic periodontitis and periodontally healthy subjects.

M A Listgarten, C H Lai, C I Evian.   

Abstract

Circulating antibody levels to four strains of Actinobacillus actinomycetemcomitans (Aa) were determined by means of an indirect immunofluorescent technique in three groups of 21 subjects each, including one with juvenile periodontitis (JP), one with chronic periodontitis (CP) and one free of periodontal disease (N). Mean levels of antibody to Aa were significantly elevated in the JP group as compared to the CP and N groups with respect to strains Y4, 29522 and 29524, but not strain 29523. Since strains Y4, 29522 and 29524 contain a leukotoxin that is missing from strain 29523, the results suggest that the leukotoxin could account for the difference in the immune response among the three groups of subjects. Varying the end-point considered to represent positive fluorescence did not significantly affect the results, although discrimination among the three groups appeared to be somewhat better at lower intensities of fluorescence. Because of wide variations in antibody titers recorded in individual subjects, elevated levels of antibody to certain strains of Aa may not be useful as a primary diagnostic test for JP, but may be of value in confirming an otherwise uncertain clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7033301     DOI: 10.1111/j.1600-051x.1981.tb02027.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  24 in total

1.  Precipitating antibody against lipopolysaccharide of Haemophilus actinomycetemcomitans in human serum.

Authors:  K Okuda; T Kato; Y Naito; I Takazoe
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

2.  Monoclonal antibodies to Actinobacillus actinomycetemcomitans.

Authors:  D A Place; N C Scidmore; W P McArthur
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

3.  Immunoglobulin allotypes and immunoglobulin G subclass responses to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in early-onset periodontitis.

Authors:  J I Choi; M H Ha; J H Kim; S J Kim
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans.

Authors:  J M DiRienzo; C C Tsai; B J Shenker; N S Taichman; E T Lally
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

5.  Application of monoclonal antibodies to the detection of black-pigmented Bacteroides spp. in subgingival plaques by immunoslot blot assay.

Authors:  S Hanazawa; S Tanaka; M Kin; S Amano; K Nakada; T Masuda; S Kitano
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

6.  Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

Authors:  T Y Ling; T J Sims; H A Chen; C W Whitney; B J Moncla; L D Engel; R C Page
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

7.  Identification and distribution of immunocompetent cells in inflamed gingiva of human chronic periodontitis.

Authors:  H Okada; T Kida; H Yamagami
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

8.  Avidity of antibody responses to Actinobacillus actinomycetemcomitans in periodontitis.

Authors:  D S O'Dell; J L Ebersole
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

9.  Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals.

Authors:  H Lu; M Wang; J C Gunsolley; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Characterization of an inducible bacteriophage from a leukotoxic strain of Actinobacillus actinomycetemcomitans.

Authors:  R H Stevens; B F Hammond; C H Lai
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.